Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
HSCS
HSCS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HSCS News
HeartSciences Secures European Patent for AI-Driven ECG Technology
Jun 11 2026
Newsfilter
HeartSciences Launches AI-ECG Algorithm Marketplace with FDA-Cleared Model
Jun 02 2026
Newsfilter
HeartSciences Achieves Epic Toolbox Designation for MyoVista Insights
Mar 25 2026
Newsfilter
Heart Test Laboratories Q3 Earnings Beat Expectations
Mar 17 2026
seekingalpha
HeartSciences Partners with Cibolo Health for ECG Management
Jan 29 2026
Newsfilter
HeartSciences Submits MyoVista Device to FDA, Advancing AI ECG Technology
Dec 15 2025
Globenewswire
HeartSciences Submits MyoVista Device for FDA 510(k) Clearance
Dec 15 2025
Newsfilter
Ascendiant Capital Reaffirms Buy Rating on HeartSciences, Reduces Price Target to $9
Oct 01 2025
Benzinga
HeartSciences Shares Business Update and Announces Financial Results for First Quarter of Fiscal 2026
Sep 11 2025
Newsfilter
Join the Live Stream of Day 1 at the Emerging Growth Conference 85 on August 20; Registration Now Open
Aug 18 2025
Globenewswire
HeartSciences Announces Conference Participation and Investor Webinar
Aug 15 2025
Newsfilter
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
Jun 04 2025
Newsfilter
HeartSciences: FDA Grants Breakthrough Device Designation For Aortic Stenosis ECG Algorithm
Jun 04 2025
NASDAQ.COM
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value
Jun 03 2025
Newsfilter
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
May 29 2025
Newsfilter
Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream
May 19 2025
Globenewswire
Show More News
